You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 9, September 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (16)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Herpes
 •Alert me on articles by topic

Human Herpesviruses 6 and 7

New Roles Yet to Be Discovered?

Arch Dermatol. 1998;134:1155-1157.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

TO THINK that several years ago we thought we knew all there was to know about herpesviruses, and then 3 new members of this family were identified over the past decade: human herpesvirus (HHV) 6 ,7, and 8. Because HHV-6 and HHV-7 are similar, they might have similar consequences in human pathology. These HHVs were first isolated in 1986 and 1990, respectively, from the peripheral blood of patients with lymphoproliferative disorders or human immunodeficiency virus infection and normal levels of CD4+ T lymphocytes.1-2 They belong to the subfamily of Betaherpesvirinae and share strong genomic and phenotypic properties with human cytomegalovirus (CMV).3 Human herpesvirus 6 and 7 are ubiquitous in the human population, and approximately 90% of adults are seropositive for them.3 Replication of these viruses during the acute phase of infection occurs mainly in the CD4+ T lymphocytes. The CD4 molecule is part of the HHV-7 receptor but not the . . . [Full Text of this Article]

ADR COULD ACCOUNT FOR ALL THE CLINICAL SIGNS


VIRAL REACTIVATION COULD ACCOUNT FOR ALL THE CLINICAL SIGNS

RELATED ARTICLES

Human Herpesvirus 6 Infection as a Risk Factor for the Development of Severe Drug-Induced Hypersensitivity Syndrome
Yosuke Suzuki, Reiko Inagi, Toshiya Aono, Koichi Yamanishi, and Tetsuo Shiohara
Arch Dermatol. 1998;134(9):1108-1112.
ABSTRACT | FULL TEXT  

Severe Hypersensitivity Syndrome Due to Sulfasalazine Associated With Reactivation of Human Herpesvirus 6
Mikiko Tohyama, Yoko Yahata, Masaki Yasukawa, Reiko Inagi, Yoshio Urano, Koichi Yamanishi, and Koji Hashimoto
Arch Dermatol. 1998;134(9):1113-1117.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A novel homologue of Human herpesvirus 6 in chimpanzees
Lacoste et al.
J. Gen. Virol. 2005;86:2135-2140.
ABSTRACT | FULL TEXT  

Drug-Induced Hypersensitivity Syndrome in Pediatric Patients
Carroll et al.
Pediatrics 2001;108:485-492.
ABSTRACT | FULL TEXT  

Association of Human Herpesvirus 6 Infection With Drug Reaction With Eosinophilia and Systemic Symptoms
Descamps et al.
Arch Dermatol 2001;137:301-304.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.